Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...

Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...

Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.

Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...

Dan is currently a trade media relations expert at Sartorius, and he formerly led the news domain of Bioprocess International ...

University students attended Biotech Week Boston Campus to learn about career options in a volatile biopharma industry and ...

The successful European Medicines Agency inspection is the latest in a string of positive news for the big Chinese biotech ...

Earlier this month, aeronautics company Helogen announced a collaboration with leading institution University College London (UCL) to manufacture biomaterials in space. The company will also ...

Sanofi announced the inauguration of the Charles Best Building in Toronto, Canada, to support production of the firm’s Fluzone High-Dose influenza vaccine. The company stated in a public release that ...

The good manufacturing practice (GMP) obligations of a licensed biomanufacturing site do not ease when the closure announcement is made. If anything, they intensify yet must be met by a team whose ...

Increasingly, viral-clearance studies depend on integration of complementary analytical approaches for impurity detection and characterization.